KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) FCF Margin (2016 - 2025)

Medpace Holdings (MEDP) has disclosed FCF Margin for 11 consecutive years, with 26.55% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 756.0% year-over-year to 26.55%, compared with a TTM value of 96.25% through Dec 2025, up 6911.0%, and an annual FY2025 reading of 26.95%, down 19.0% over the prior year.
  • FCF Margin was 26.55% for Q4 2025 at Medpace Holdings, down from 34.11% in the prior quarter.
  • Across five years, FCF Margin topped out at 34.11% in Q4 2024 and bottomed at 11.18% in Q1 2022.
  • Average FCF Margin over 5 years is 23.21%, with a median of 22.23% recorded in 2021.
  • The sharpest move saw FCF Margin tumbled -1761bps in 2021, then surged 1254bps in 2024.
  • Year by year, FCF Margin stood at 20.02% in 2021, then skyrocketed by 62bps to 32.34% in 2022, then decreased by -9bps to 29.38% in 2023, then grew by 16bps to 34.11% in 2024, then dropped by -22bps to 26.55% in 2025.
  • Business Quant data shows FCF Margin for MEDP at 26.55% in Q4 2025, 34.11% in Q4 2024, and 25.98% in Q3 2024.